75,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
38 °P sammeln
  • Broschiertes Buch

This book examines new technologies (device and pharmacologic) that have evolved over the past few years in treating peripheral arterial disease. Chapters offer optimal strategies to treat PAD, supported by peer-reviewed data. The pillars of this strategy will focus on (a) changing vessel compliance to allow better lumen expansion, (b) less recoil and dissections, and (c) less bailout stenting. Chapters also review embolic protection devices and apply the adjunctive use of anti-proliferative therapy to maintain good long term outcomes. In addition, the book reviews drug coated balloons and…mehr

Produktbeschreibung
This book examines new technologies (device and pharmacologic) that have evolved over the past few years in treating peripheral arterial disease. Chapters offer optimal strategies to treat PAD, supported by peer-reviewed data. The pillars of this strategy will focus on (a) changing vessel compliance to allow better lumen expansion, (b) less recoil and dissections, and (c) less bailout stenting. Chapters also review embolic protection devices and apply the adjunctive use of anti-proliferative therapy to maintain good long term outcomes. In addition, the book reviews drug coated balloons and drug eluting stent technologies and other means of drug delivery into the vessel wall. The goal of this book is to discuss all these emerging technologies under the strategy of treating patients with the focus on both acute and long term outcomes. Featuring world renown experts, this book offers a critical and comprehensive overview of the current data and future directions that would pave the wayfor optimal PAD management.

Peripheral Arterial Interventions is an essential resource for physicians, residents, fellows, and medical students in cardiology, radiology, vascular surgery, primary care, and health promotion and disease prevention as well as internal and vascular medicine specialists.

Autorenporträt
Nicolas W. Shammas, MD, MS, EJD, FACC, FSCAI, FSVM, FICA, is an interventional cardiologist with Cardiovascular Medicine P.C., the Genesis Heart Institute, and UnityPoint-Trinity in the Quad Cities, Iowa. He is also the Founder, President, and Research Director of the Midwest Cardiovascular Research Foundation and an adjunct clinical associate professor of Medicine at the University of Iowa Hospitals and Clinics. Dr. Shammas has been performing interventional procedures for 27 years in both coronary and peripheral vascular interventions. He has published more than 400 manuscripts, abstracts, book chapters, and books and has been the principal investigator on more than 220 national clinical trials. His main research interests are the development of techniques for optimal endovascular interventions-with a focus on the triad of vessel prepping, distal embolic protection, and anti-restenotic therapies-and the management of arterial and venous thrombotic occlusions anddeep venous interventions. Dr. Shammas has been an editorial board member and a reviewer for numerous journals. He is also the editor of the Textbook of Atherectomy, the Atherothrombotic Embolization in Cardiovascular Medicine, and the Infrainguinal Endovascular Interventions: Leaving the Least Behind. Dr. Shammas is a fellow of the American College of Cardiology and the Society of Cardiac Angiography and Interventions. He is the immediate past Governor for the Iowa Chapter of the American College of Cardiology (2017-2020). He has lectured both nationally and internationally on atherectomy, venous disease, management of acute and subacute thrombotic disease, and distal embolization in peripheral vascular disease.